PharVision Advisers »

Day One Biopharmaceuticals I shares owned by PharVision Advisers

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $299k 42k 7.05

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Day One Biopharmaceuticals I

FMR
BlackRock
Atlas Venture Life Science Advisors
Vanguard Group
Deerfield Management Company
Franklin Resources
Rubric Capital Management
State Street Corporation
Vestal Point Capital
Pictet Asset Management Holding SA
Alyeska Investment Group
Braidwell
Geode Capital Management
AIGH Capital Management
MAK Capital One

View all funds holding Day One Biopharmaceuticals I